Without systematic tracking, you may either stop treatment too early (missing additional benefits) or continue too long at a dose that is not working
Xiao Q, Boushey RP, Cino M, Drucker DJ, Brubaker PL (2000) Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease
If planning pregnancy, Wegovy should be discontinued at least 2 months before attempting to conceive
At week 20, bodyweight reductions were observed to be greater with cagrilintide 1.2 and 2.4 mg than with placebo (15.7% for cagrilintide 1.2 mg and 17.1% for cagrilintide 2.4 mg vs
In different tumor cell lines, the RASRAFMEK pathway is capable of altering their susceptibility to ferroptosis (Yang and Stockwell, 2008)
Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis